pubmed-article:7309974 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:7309974 | lifeskim:mentions | umls-concept:C0700219 | lld:lifeskim |
pubmed-article:7309974 | lifeskim:mentions | umls-concept:C0025202 | lld:lifeskim |
pubmed-article:7309974 | lifeskim:mentions | umls-concept:C0220901 | lld:lifeskim |
pubmed-article:7309974 | pubmed:issue | 11 | lld:pubmed |
pubmed-article:7309974 | pubmed:dateCreated | 1982-2-12 | lld:pubmed |
pubmed-article:7309974 | pubmed:abstractText | In a prospective study of 178 patients with malignant melanoma, a subset of 33 patients (18.5%) was identified to be at significantly higher risk for developing metastatic disease based on history of cigarette smoking. Patients in this high-risk group (current smokers with a greater than 15 pack-years of smoking history) had two-year disease-free survival rates of 74.2%. versus 92.3% for the remaining patients (p = 0.008). A possible explanation of this phenomenon is that chronic smoking diminishes host defense mechanisms and results in an adverse affect on the biologic behavior of established malignant melanomas. | lld:pubmed |
pubmed-article:7309974 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:7309974 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:7309974 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:7309974 | pubmed:language | eng | lld:pubmed |
pubmed-article:7309974 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:7309974 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:7309974 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:7309974 | pubmed:month | Nov | lld:pubmed |
pubmed-article:7309974 | pubmed:issn | 0148-0812 | lld:pubmed |
pubmed-article:7309974 | pubmed:author | pubmed-author:LevineJJ | lld:pubmed |
pubmed-article:7309974 | pubmed:author | pubmed-author:KopfA WAW | lld:pubmed |
pubmed-article:7309974 | pubmed:author | pubmed-author:FriedmanR JRJ | lld:pubmed |
pubmed-article:7309974 | pubmed:author | pubmed-author:RigelD SDS | lld:pubmed |
pubmed-article:7309974 | pubmed:author | pubmed-author:LevensteinMM | lld:pubmed |
pubmed-article:7309974 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:7309974 | pubmed:volume | 7 | lld:pubmed |
pubmed-article:7309974 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:7309974 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:7309974 | pubmed:pagination | 889-91 | lld:pubmed |
pubmed-article:7309974 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
pubmed-article:7309974 | pubmed:meshHeading | pubmed-meshheading:7309974-... | lld:pubmed |
pubmed-article:7309974 | pubmed:meshHeading | pubmed-meshheading:7309974-... | lld:pubmed |
pubmed-article:7309974 | pubmed:meshHeading | pubmed-meshheading:7309974-... | lld:pubmed |
pubmed-article:7309974 | pubmed:meshHeading | pubmed-meshheading:7309974-... | lld:pubmed |
pubmed-article:7309974 | pubmed:meshHeading | pubmed-meshheading:7309974-... | lld:pubmed |
pubmed-article:7309974 | pubmed:meshHeading | pubmed-meshheading:7309974-... | lld:pubmed |
pubmed-article:7309974 | pubmed:meshHeading | pubmed-meshheading:7309974-... | lld:pubmed |
pubmed-article:7309974 | pubmed:meshHeading | pubmed-meshheading:7309974-... | lld:pubmed |
pubmed-article:7309974 | pubmed:meshHeading | pubmed-meshheading:7309974-... | lld:pubmed |
pubmed-article:7309974 | pubmed:meshHeading | pubmed-meshheading:7309974-... | lld:pubmed |
pubmed-article:7309974 | pubmed:year | 1981 | lld:pubmed |
pubmed-article:7309974 | pubmed:articleTitle | Cigarette smoking and malignant melanoma. Prognostic implications. | lld:pubmed |
pubmed-article:7309974 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:7309974 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
pubmed-article:7309974 | pubmed:publicationType | Research Support, U.S. Gov't, Non-P.H.S. | lld:pubmed |
pubmed-article:7309974 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |